#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cortical dysplasia Uterine leiomyosarcoma Congenital myopathy Glycogen storage disease type II Small for dates baby Immunodeficiency Osteopetrosis Juvenile chronic myelomonocytic leukaemia Still's disease Friedreich's ataxia Cluster headache Squamous cell carcinoma of the oral cavity Gastrointestinal stromal tumour Alagille syndrome Cystic fibrosis lung More trials…

    Learn about Rare Diseases

    Haemophagocytic lymphohistiocytosis – Diagnostics Von Willebrand’s disease – Treatment Gaucher’s disease type III Encephalitis autoimmune Mantle cell lymphoma – Treatment Familial haemophagocytic lymphohistiocytosis – Life with Disease VEXAS syndrome – Trials in Disease Chondrosarcoma metastatic – Diagnostics Splenic marginal zone lymphoma – Trials in Disease Von Willebrand’s disease – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nirogacestat Hydrobromide Immunglobulin Lidocaine Protamine Sulfate Esomeprazole Dinutuximab Beta Trazodone Utreloxastat Nemolizumab Blomia Tropicalis Lamivudine Prs-344 Timolol Maleate Dirocaftor Secukinumab Timothy Grass Pollen Extract Pd01B Givinostat Ruxolitinib Betamethasone Dipropionate More therapies…

    Learn about Your Condition

    Aneurysm ruptured Lung adenocarcinoma K-ras gene mutation Small intestine leiomyosarcoma Onychomycosis Leiomyosarcoma recurrent Oedema peripheral Hereditary angioedema Ventricular tachycardia Endometrial cancer Liver transplant rejection Metastases to lymph nodes Fungal infection Adenomatous polyposis coli Hypotonia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pathological Conditions, Signs and Symptoms

  • Study of NP137 with carboplatin, paclitaxel and pembrolizumab combination therapy for patients with advanced endometrial or cervical cancer who had prior chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Cervix carcinoma
    • Endometrial cancer
    Investigated Drugs:
    • Human Monoclonal Igg1 Antibody Against Netrin-1
    • Carboplatin
    • Paclitaxel
    France

  • Study on the Effects of Sparsentan and Irbesartan for Patients with Primary Focal Segmental Glomerulosclerosis (FSGS)

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Focal segmental glomerulosclerosis
    Investigated Drugs:
    • Irbesartan
    • Sparsentan
    Belgium Croatia Czechia Denmark Estonia France +6

  • Study on the Safety of Radiation and Nivolumab for Patients with Esophageal Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    Investigated Drugs:
    • Nivolumab
    Norway

  • Study of sildenafil to improve walking distance in patients with peripheral arterial disease and intermittent claudication

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • Microcrystalline Cellulose
    • Sildenafil Citrate
    France

  • Study on Denosumab for Healing Bone Fractures in Diabetic Patients with Charcot Foot

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Neuropathic arthropathy
    • Diabetes mellitus
    Investigated Drugs:
    • Saline
    • Denosumab
    The Netherlands

  • Study on Improving Quality of Life in Cancer Patients Using Dronabinol and Cannabidiol

    Not recruiting

    2 1
    Investigated Drugs:
    • Dronabinol
    • Cannabidiol
    Germany
Previous Page
1 … 15 16 17 18 19 … 21
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!